Colossal Biosciences Acquires Pet Cloning Company to Advance De-Extinction Efforts

Colossal Biosciences Acquires Pet Cloning Company to Advance De-Extinction Efforts

Colossal Biosciences, a “de-extinction” startup working to revive long-lost species such as the woolly mammoth, is acquiring a Texas-based company with an equally eye-catching mission: cloning pets. The deal marks Colossal’s first-ever acquisition and brings under its wings ViaGen, a venture specializing in reproducing deceased dogs, cats and horses. Its star-studded client list features Barbra…

Read More
Porsche’s 99% Profit Tumble Signals Trouble for Luxury Brands Worldwide

Porsche’s 99% Profit Tumble Signals Trouble for Luxury Brands Worldwide

Porsche’s billion-dollar loss last week isn’t just a setback for one of the world’s most profitable automakers—it’s a warning shot for the entire luxury economy. After years of record profits fueled by cheap credit and post-pandemic “revenge spending,” the German carmaker’s sudden slowdown shows that even the world’s most coveted brands are losing altitude as…

Read More
This Longevity Startup Is Bringing Anti-Aging Gene Therapy to Human Trials

This Longevity Startup Is Bringing Anti-Aging Gene Therapy to Human Trials

Life Biosciences, a Boston-based biotechnology company founded in 2017 by Harvard Medical School professor David Sinclair, is poised to become the first to conduct human clinical trials for a therapy that targets aging by rejuvenating cells without altering their core function. The company is developing a cellular reprogramming treatment that, if successful, could address a wide…

Read More